Pre-Eclampsia And Growth Restriction: a Longitudinal Study
NCT02379832 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 76
Last updated 2019-07-23
Summary
Preeclampsia may have several causes leading to different characteristics of the pathology. Differentiation between the "type of preeclampsia" would help to treat patients more accurately. This project aims to identify early markers that are specific to each type of preeclampsia (early or late, with or without growth restriction). Through a case-control study, many data will be collected prospectively (serum markers, ultrasonographic markers, maternal factors) among nulliparous women with no sign of preeclampsia (as soon as the first trimester) and nulliparous women with preeclampsia (at diagnosis).
Conditions
- Preeclampsia
- Severe Preeclampsia
- Fetal Growth Restriction
- Preterm Birth
Sponsors & Collaborators
-
Chaire Jeanne-et-Jean-Louis Lévesque en périnatalogie
collaborator UNKNOWN -
Laval University
collaborator OTHER -
CHU de Quebec-Universite Laval
lead OTHER
Principal Investigators
-
Emmanuel Bujold, MD, MSc · CHU de Québec
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-03-31
- Primary Completion
- 2016-09-30
- Completion
- 2017-12-31
Countries
- Canada
Study Locations
More Related Trials
-
First Trimester Placental Assessment in the Screening of Preeclampsia and Intrauterine Growth Restriction
NCT02879942 ·Status: COMPLETED
-
Study of the Physiology of Pre-eclampsia and Vascular IUGR With Constitution of a Biological Collection
NCT03626233 ·Status: UNKNOWN
-
Interest of Circulating Endothelial Biomarkers in Vascular Pregnancy Complications
NCT00485784 ·Status: COMPLETED ·Phase: NA
-
Prediction of Early Pre-eclampsia From Maternal Factors, Biophysical and Biochemical Markers at First Trimester
NCT02990767 ·Status: UNKNOWN
-
Predicting Late-onset Preeclampsia at 10-14 Weeks of Pregnancy
NCT04075708 ·Status: COMPLETED
-
Left Ventricular and Endothelial Function in Preeclampsia
NCT00201500 ·Status: COMPLETED
-
Vascular Biomarkers Predictive of the Progression From Hypertensive Disorders in Pregnancy to Preeclampsia in Pregnant Women
NCT04520048 ·Status: RECRUITING ·Phase: NA
-
Biological Markers of Disease in the Prediction of Preterm Delivery, Preeclampsia and Intra-Uterine Growth Retardation: A Longtitudinal Study
NCT00340899 ·Status: COMPLETED
-
Prediction of Preeclampsia by Comprehensive Markers.
NCT03665623 ·Status: COMPLETED
-
Detecting Early Onset Pre-eclampsia and Use of Placental Growth Factor (PlGF) for Marker of Trisomy 21
NCT01387776 ·Status: TERMINATED
-
Evaluation of the Serum Markers sFLt1 and PlGF for the Prediction of the Complications of the Placental Vascular Pathologies in the 3rd Quarter of the Pregnancy.
NCT03455387 ·Status: COMPLETED
-
Antenatal Detection of Fetal Growth Restriction and Stillbirths Rate.
NCT01995968 ·Status: UNKNOWN
-
Biobank on Prematurity, Preeclampsia and Other Pregnancy Complications
NCT02744365 ·Status: RECRUITING
-
Evaluation of Cardiovascular Risk After Preeclampsia in General Practitioners and Patients
NCT06059937 ·Status: COMPLETED
-
Comparison of Doses of Acetylsalicylic Acid in Women With Previous History of Preeclampsia
NCT01352234 ·Status: COMPLETED ·Phase: PHASE4
-
Determining the Risk Elevation After Maternity
NCT02305745 ·Status: UNKNOWN
-
sFlt-1/PlGF Ratio: Impact on the Management of Patients With Suspected Pre-eclampsia
NCT05228002 ·Status: COMPLETED ·Phase: NA
-
Longitudinal Study of Intra-Uterine Growth Restriction
NCT02382601 ·Status: RECRUITING
-
The Association Between Different Markers With Development of Maternal and Neonatal Complications in Women With Severe Preeclampsia
NCT07125599 ·Status: COMPLETED
-
Chronic Remote Ischemic Preconditioning as a Complement to Conventional Prenatal Care for Preeclampsia
NCT05564988 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Minimally-invasive Assessment of Cardiac Output in Severe Preeclampsia
NCT00465114 ·Status: WITHDRAWN
-
Preeclampsia Subtypes and Surrogate Markers of CVD Risk
NCT02337049 ·Status: UNKNOWN
-
MorbiMortality Amelioration in Preeclamptic Primiparas Study. MoMA Pre Prim Study
NCT00763672 ·Status: COMPLETED ·Phase: NA
-
Placental Expression of EG-VEGF and Its PROKR1 and PROKR2 Receptors in Preeclampsia Patients.
NCT04846686 ·Status: COMPLETED
-
Evaluation of Educational Tools for Pregnant Women
NCT01858324 ·Status: COMPLETED ·Phase: NA